BAYRY
Bayer AG PK
Bayer AG PK historical holders
total: 1
Kahn Brothers Group Bayer AG PK transactions over time
- Total transactions:
- 10
- New positions:
- 1
- Added:
- 6
- Reduced:
- 3
- Held since:
- 2023 Q4
- Held for:
- 10 quarters
- Latest activity:
- 2026 Q1
Kahn Brothers Group has been an institutional investor in Bayer AG PK (BAYRY) since 2023 Q4. According to 2026 Q1 report, Kahn Brothers Group holds 6,513,893 shares with a market value of roughly $74.78M representing 13.26% of their equity portfolio. The fund/company first acquired BAYRY in 2023 Q4, initially purchasing 712,500 shares. Since the initial investment, Kahn Brothers Group has made 9 more transactions in this position.
Does Kahn Brothers Group still hold BAYRY?
Yes, Kahn Brothers Group continues to hold Bayer AG PK (BAYRY). According to their 2026 Q1 report, they maintain a position of 6,513,893 shares valued at approximately $74.78M, representing 13.26% of their equity portfolio.
When did Kahn Brothers Group first invest in BAYRY?
Kahn Brothers Group first invested in Bayer AG PK (BAYRY) in 2023 Q4 at the reported quarter-end price of $9.23 per share, acquiring 712,500 shares in their initial purchase.
What is Kahn Brothers Group's average cost basis for BAYRY?
Based on historical transaction data, Kahn Brothers Group's estimated cost basis for Bayer AG PK (BAYRY) is approximately $7.34 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $7.34
- Weighted AVG sell price:
- $6.80
BAYRY transactions history by Kahn Brothers Group
10 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
13.26%
|
6,513,893
|
$11.48
|
$74,777,216
|
-3.56% (-240,398)
|
-0.49%
|
|
2025 Q4
|
12.94%
|
6,754,291
|
$10.82
|
$73,082,408
|
-0.49% (-32,962)
|
-0.07%
|
|
2025 Q3
|
10.58%
|
6,787,253
|
$8.29
|
$56,266,389
|
+0.87% (+58,350)
|
+0.09%
|
|
2025 Q2
|
10.19%
|
6,728,903
|
$7.54
|
$50,734,969
|
+2.36% (+155,210)
|
+0.24%
|
|
2025 Q1
|
8.00%
|
6,573,693
|
$6.02
|
$39,573,638
|
+45.88% (+2,067,470)
|
+2.52%
|
|
2024 Q4
|
4.78%
|
4,506,223
|
$4.88
|
$21,989,998
|
-12.66% (-653,317)
|
-0.55%
|
|
2024 Q3
|
7.53%
|
5,159,540
|
$8.47
|
$43,701,503
|
+17.95% (+785,085)
|
+1.15%
|
|
2024 Q2
|
5.18%
|
4,374,455
|
$7.04
|
$30,795,897
|
+41.15% (+1,275,315)
|
+1.51%
|
|
2024 Q1
|
3.52%
|
3,099,140
|
$7.66
|
$23,739,224
|
+334.97% (+2,386,640)
|
+2.71%
|
|
2023 Q4
|
1.04%
|
712,500
|
$9.23
|
$6,576,000
|
new
|
+1.04%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.